118 related articles for article (PubMed ID: 20152256)
1. Aspirin--a drug whose time has gone?
Tapp L; Shantsila E; Lip GY
Am J Cardiol; 2010 Feb; 105(4):577-8. PubMed ID: 20152256
[No Abstract] [Full Text] [Related]
2. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
Fisher M; Knappertz V
Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
[No Abstract] [Full Text] [Related]
3. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
4. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.
Serebruany VL; Steinhubl SR; Berger PB; Malinin AI; Baggish JS; Bhatt DL; Topol EJ
Am J Cardiol; 2005 May; 95(10):1218-22. PubMed ID: 15877994
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
[No Abstract] [Full Text] [Related]
6. Oral anticoagulant treatment with and without aspirin.
Altman R; Rouvier J; Gurfinkel E
Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
[TBL] [Abstract][Full Text] [Related]
7. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
Mooe T
Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
[No Abstract] [Full Text] [Related]
8. [Clopidogrel as basic therapy in high-risk stroke patients].
Mattle HP
Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
[No Abstract] [Full Text] [Related]
9. [Aspirin and risk of perioperative hemorrhage].
Haas S
Chirurg; 2006 May; 77(5):453-8. PubMed ID: 16541272
[No Abstract] [Full Text] [Related]
10. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
Sauer H; Leschke M
Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
[No Abstract] [Full Text] [Related]
11. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
Walker CW; Dawley CA; Fletcher SF
Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
[No Abstract] [Full Text] [Related]
12. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
Mooe T
Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
[No Abstract] [Full Text] [Related]
13. Antiplatelet therapy: aspirin.
Steinhubl SR
J Invasive Cardiol; 2003 Mar; 15 Suppl B():11B-16B; discussion 16B. PubMed ID: 12724581
[No Abstract] [Full Text] [Related]
14. [Must platelet aggregation inhibitors be discontinued before surgery?].
Schieber M; Sechtem U
Dtsch Med Wochenschr; 2004 Feb; 129(6):276. PubMed ID: 14750057
[No Abstract] [Full Text] [Related]
15. An aspirin a day: are we barking up the wrong willow tree?
Krantz MJ; Berger JS; Hiatt WR
Pharmacotherapy; 2010 Feb; 30(2):115-8. PubMed ID: 20099985
[No Abstract] [Full Text] [Related]
16. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
Hobson A; Curzen N
Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
[No Abstract] [Full Text] [Related]
17. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
18. Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation.
Tompkins C; Henrikson CA
Cardiol J; 2011; 18(1):103-9. PubMed ID: 21305497
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
Moussa ID; Colombo A
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
[TBL] [Abstract][Full Text] [Related]
20. [Polycythemia vera--focus on the Hb value. Future treatment can maybe result in disease remission].
Johansson P; Andreasson B; Samuelsson J
Lakartidningen; 2009 Jan 14-20; 106(3):104-9. PubMed ID: 19248459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
